Does exposure to conflict of interest policies in psychiatry residency affect antidepressant prescribing?

Medical Care

Volumn 51, Issue 2, 2013, Pages 199-203

  Epstein, Andrew J ^a,b,c   Busch, Susan H ^d   Busch, Alisa B ^e,f   Asch, David A ^a,b,c   Barry, Colleen L ^c,g  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d YALE UNIVERSITY   (United States)

^e MCLEAN HOSPITAL   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

drug utilization; pharmaceutical policy; physician practice patterns; psychiatry

Indexed keywords

ANTIDEPRESSANT AGENT;

ARTICLE; CONFLICT OF INTEREST; DRUG INDUSTRY; DRUG UTILIZATION; EDUCATION PROGRAM; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; POLICY; POSTGRADUATE STUDENT; PRESCRIPTION; PRIORITY JOURNAL; PSYCHIATRIST; RESIDENCY EDUCATION;

ANTIDEPRESSIVE AGENTS; CONFLICT OF INTEREST; DRUG INDUSTRY; HUMANS; INTERNSHIP AND RESIDENCY; LINEAR MODELS; ORGANIZATIONAL POLICY; PHYSICIAN'S PRACTICE PATTERNS; PSYCHIATRY; UNITED STATES;

EID: 84872844705     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/MLR.0b013e318277eb19     Document Type: Article

References (34)

1. Brennan TA, Rothman DJ, Blank L, et al. Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. JAMA. 2006;295:429-433.
2. Harris G, Carey B. Researchers fail to reveal full drug pay, in New York Times. 2008. http://www.nytimes.com/2008/10/04/health/policy/04drug. html. Accessed October 3, 2008.
3. Sierles FS, Brodkey AC, Cleary LM, et al. Medical students' exposure to and attitudes about drug company interactions: a national survey. JAMA. 2005;294:1034-1042.
4. Hodges B. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks. CMAJ. 1995;153:553-559.
5. Reeder M, Dougherty J, White LJ. Pharmaceutical representatives and emergency medicine residents: a national survey. Ann Emerg Med. 1993;22:1593-1596.
6. Campbell EG, Gruen RL, Mountford J, et al. A national survey of physician-industry relationships. N Engl J Med. 2007;356: 1742-1750.
7. Zipkin DA, Steinman MA. Interactions between pharmaceutical representatives and doctors in training. A thematic review. J Gen Intern Med. 2005;20:777-786.
8. Association of American Medical Colleges. Industry Funding of Medical Education. A Report of the AAMC Task Force. 2008.
9. American Medical Student Association 2008 Score Card. Available at: http://www.amsascorecard.org/documents/0000/0204/Scorecard2008Archive. pdf. Accessed September 11, 2012.
10. Gonul F, Franklin C, Petrova E, et al. Promotion of prescription drugs and Its impact on physicians' choice behavior. J Mark. 2001;65: 79-90.
11. Lurie N, Rich EC, Simpson DE. Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff. J Gen Intern Med. 1990;5:240-243.
12. Caudill TS, Johnson MS, Rich EC, et al. Physicians, pharmaceutical sales representatives, and the cost of prescribing. Arch Fam Med. 1996;5:201-206.
13. Peay MY, Peay ER. The role of commercial sources in the adoption of a new drug. Soc Sci Med. 1988;26:1183-1189.
14. Bower AD, Burkett GL. Family physicians and generic drugs: a study of recognition, information sources, prescribing attitudes, and practices. J Fam Pract. 1987;24:612-616.
15. Cleary JD. Impact of pharmaceutical sales representatives on physician antibiotic prescribing. J Pharm Technol. 1992;8:27-29.
16. Mizik N, Jacobson R. Are physicians "easy marks"? Quantifying the effects of detailing and sampling on new prescriptions. Manag Sci. 2004;50:1704-1715.
17. Orlowski JP, Wateska L. The effects of pharmaceutical firm enticements on physician prescribing patterns. There's no such thing as a free lunch. Chest. 1992;102:270-273.
18. Manchanda P, Chintagunta P. Responsiveness of physician prescription behavior to sales force effort: an individual level analysis. Mark Lett. 2004;15:129-145.
19. Adair RF, Holmgren LR. Do drug samples influence resident prescribing behavior? A randomized trial. Am J Med. 2005;118:881-884.
20. Chew LD, O'Young T, Hazlet T, et al. A physician survey of the effect of drug sample availability on physicians' behavior. J Gen Intern Med. 2001;15:478-483.
21. Institute for Medicine as a Profession. Conflict of Interest Policy Database. Available at: http://www.imapny.org/conflicts-of-interest/search- policies. Accessed September 11, 2012.
22. Pharmaceutical Research and Manufacturers of America. PhRMA Code of Interactions with Healthcare Professionals. 2002.
23. Cegedim Strategic Data. 2010 US pharma promotion spending. July 2011. Paris: Cegedim.
24. Nelson P. Advertising as information. J Polit Econ. 1974;82:729-754.
25. Leffler KB. Persuasion or information? The economics of prescription drug advertising. J Law Econ. 1981;24:45-74.
26. Rubin P. Pharmaceutical marketing: medical and industry biases. J Pharm Finance Econ Policy. 2004;13:65.
27. Lazarus A. The role of the pharmaceutical industry in medical education in psychiatry. Acad Psychiatry. 2006;30:40-44.
28. Angell M. The Truth About Drug Companies: How They Deceive Us and What To Do About It. New York: Random House; 2004.
29. Huskamp HA, Busch AB, Domino ME, et al. Antidepressant reformulations: who uses them, and what are the benefits? Health Aff. 2009;28:734-745.
30. Donohue JM, Cevasco M, Rosenthal MB. A decade of direct-to-consumer advertising of prescription drugs. N Engl J Med. 2007;357:673-681.
31. Mark TL, Levit KR, Vandivort-Warren R, et al. Changes in US spending on mental health and substance abuse treatment, 1986-2005. Health Aff. 2001;30:284-292.
32. Pratt LA, Brody DJ, Gu Q. Antidepressant use in persons aged 12 and over: United States, 2005-2008. US DHHS, Centers for Disease Control and Prevention, National Center for Health Statistics, NCHS Data Brief 76. 2011. Available at: http://www.cdc.gov/nchs/data/databriefs/db76. pdf. Accessed September 11, 2012.
33. Pereira J. Emory professor steps down, in Wall Street Journal. 2008.
34. Gibbons RV, Landry FJ, Blouch DL. A comparison of physicians' and patients' attitudes toward pharmaceutical industry gifts. J Gen Intern Med. 1998;13:151-154.